SCHEMBL2062328

SCHEMBL2062328

CCOC(=O)C1C2CCC1c1cc(C(=O)OC)ccc1C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 5/20 0.41
PTGER4 P35408 1/20 0.39
HSD11B1 P28845 1/20 0.39
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 3/20 0.37
POLB P06746 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
DRD3 P35462 1/20 0.37
CHRNB2 P17787 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15016502 0.70 ALDH1A1 (0.67) KDM4EALDH1A1MAPTHPGDHTT
SCHEMBL5073393 0.68 ALDH1A1 (0.45) KDM4EALDH1A1RAB9ANPC1MAPT
SCHEMBL15016469 0.67 CHRNB2 (0.43) KDM4EALDH1A1HSD11B1HTTPOLB
SCHEMBL16527088 0.65 CHRNB2 (0.46) KDM4EALDH1A1RAB9ANPC1MAPT
SCHEMBL27920400 0.65 ACHE (0.58) MAPTMEN1KMT2ACHRNB2CHRNA4
SCHEMBL803477 0.65 ACHE (0.58) MAPTMEN1KMT2ACHRNB2CHRNA4
SCHEMBL10050521 0.65 PPM1B (0.52) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL14189733 0.65 PPM1B (0.52) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL14189734 0.65 PPM1B (0.52) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL8400471 0.65 PPM1B (0.52) ALDH1A1MAPTMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148391-B2 Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors CEPHALON, INC. (US) 2012-04-03 US claimed